{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T11:54:32Z","timestamp":1773662072042,"version":"3.50.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2005,8,1]],"date-time":"2005-08-01T00:00:00Z","timestamp":1122854400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Thromb Thrombolysis"],"published-print":{"date-parts":[[2005,8]]},"DOI":"10.1007\/s11239-005-2912-2","type":"journal-article","created":{"date-parts":[[2005,8,30]],"date-time":"2005-08-30T13:38:24Z","timestamp":1125409104000},"page":"57-63","source":"Crossref","is-referenced-by-count":12,"title":["The Effect of Glycoprotein IIIa PIA1\/A2 Polymorphism on the PFA-100 Response to GP IIbIIIa Receptor Inhibitors\u2014The Importance of Anticoagulants Used"],"prefix":"10.1007","volume":"20","author":[{"given":"Katriina","family":"Aalto-Set\u00e4l\u00e4","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pekka J.","family":"Karhunen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jussi","family":"Mikkelsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kari","family":"Niemel\u00e4","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"2912_CR1","doi-asserted-by":"crossref","first-page":"3E","DOI":"10.1016\/S0002-9149(99)00083-1","volume":"83","author":"RC Becher","year":"1999","unstructured":"Becher RC. Thrombosis and the role of the platelet. Am J Cardiol 1999;83:3E\u20136E.","journal-title":"Am J Cardiol"},{"key":"2912_CR2","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1053\/euhj.2000.2515","volume":"22","author":"S Kamath","year":"2001","unstructured":"Kamath S, Blann AD, Lip GYH. Platelet activation: Assessment and quantification. Eur Heart J 2001;22:1561\u20131571.","journal-title":"Eur Heart J"},{"key":"2912_CR3","doi-asserted-by":"crossref","unstructured":"Lefkovits J, Plow EF, Topol EJ. Platelet glycoprotein IIb\/IIIa receptors in cardiovascular medicine. 1995;332:1553\u20131559.","DOI":"10.1056\/NEJM199506083322306"},{"key":"2912_CR4","first-page":"1317","volume":"285","author":"RA Bednar","year":"1998","unstructured":"Bednar RA, Gaul SL, Hamill TG, et al. Identification of low molecular weight GP IIb\/IIIa antagonists that bind preferentially to activated platelets. J Pharmacol Exp Ther 1998;285:1317\u20131326.","journal-title":"J Pharmacol Exp Ther"},{"key":"2912_CR5","doi-asserted-by":"crossref","first-page":"7E","DOI":"10.1016\/S0002-9149(99)00084-3","volume":"83","author":"JE Tcheng","year":"1999","unstructured":"Tcheng JE. Differences among the parenteral platelet glycoprotein IIb\/IIIa inhibitors and implications for treatment. Am J Cardiol 1999;83:7E\u201311E.","journal-title":"Am J Cardiol"},{"key":"2912_CR6","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0049-3848(00)00385-6","volume":"101","author":"T Dickfeld","year":"2001","unstructured":"Dickfeld T, Ruf A, Pogatsa-Murray G, et al. Differential antiplatelet effects of various glycoprotein IIbIIIa antagonists. Thrombosis Research 2001;101:53\u201364.","journal-title":"Thrombosis Research"},{"issue":"20","key":"2912_CR7","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1161\/01.CIR.100.20.2045","volume":"100","author":"E Boersma","year":"1999 Nov 16","unstructured":"Boersma E, Akkerhuis KM, Theroux P, Califf RM, Topol EJ, Simoons ML. Platelet glycoprotein IIb\/IIIa receptor inhibition in non-ST-elevation acute coronary syndromes: Early benefit during medical treatment only, with additional protection during percutaneous coronary intervention. Circulation 1999 Nov 16;100(20):2045\u20132048.","journal-title":"Circulation"},{"issue":"25","key":"2912_CR8","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1056\/NEJM200106213442501","volume":"344","author":"CP Cannon","year":"2001 Jun 21","unstructured":"Cannon CP, Weintraub WS, Demopoulos LA, et al. Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb\/IIIa inhibitor tirofiban. N Engl J Med 2001 Jun 21;344(25):1879\u20131887.","journal-title":"N Engl J Med"},{"issue":"21","key":"2912_CR9","doi-asserted-by":"crossref","first-page":"2528","DOI":"10.1161\/01.CIR.103.21.2528","volume":"103","author":"KK Wu","year":"2001 May 29","unstructured":"Wu KK, Willerson JT. Monitoring platelet function in glycoprotein IIB\/IIIA inhibitor therapy (editorial). Circulation 2001 May 29;103(21):2528\u20132530.","journal-title":"Circulation"},{"key":"2912_CR10","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1540-8183.2002.tb01034.x","volume":"15","author":"LK Jennings","year":"2002","unstructured":"Jennings LK, Jacoski MV, White MM. The pharmacodynamics of parenteral glycoprotein IIbIIIa inhibitors. J Interv Cardiol 2002;15:45\u201360.","journal-title":"J Interv Cardiol"},{"key":"2912_CR11","doi-asserted-by":"crossref","first-page":"2835","DOI":"10.1161\/01.ATV.19.12.2835","volume":"19","author":"AT Nurden","year":"1999","unstructured":"Nurden AT, Poujol C, Durrie-Jais C, Nurden P. Platelet glycoprotein IIb\/IIIa inhibitors: Basic and clinical aspects. Arterioscler Thromb Vasc Biol 1999;19:2835\u20132840.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2912_CR12","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0002-9149(99)00235-0","volume":"84","author":"MB Holmes","year":"1999","unstructured":"Holmes MB, Sobel BE, Schneider DJ. Variable responses to inhibition of fibrinogen binding induced by tirofiban and eptifibatide in blood from healthy subjects. Am J Cardiol 1999;84:203\u2013207.","journal-title":"Am J Cardiol"},{"key":"2912_CR13","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1172\/JCI114082","volume":"83","author":"PJ Newman","year":"1989","unstructured":"Newman PJ, Derbes RS, Aster RH. The human platelet alloantigens, PIA1 and PIA2, are associated with a leucine33\/proline33 amino acid polymorphism in membrane glycoprotein IIIa, and are distinguishable by DNA typing. J Clin Invest 1989;83:1778\u20131781.","journal-title":"J Clin Invest"},{"issue":"Suppl 1","key":"2912_CR14","first-page":"10","volume":"32","author":"JH Beer","year":"2000","unstructured":"Beer JH, Pederiva S, Pontiggia L. Genetics of platelet receptor single-nucleotide polymorphisms: Clinical implications in thrombosis. Ann Med 2000;32 Suppl 1:10\u201315.","journal-title":"Ann Med"},{"key":"2912_CR15","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1177\/153537020122600504","volume":"226","author":"MS Williams","year":"2001","unstructured":"Williams MS, Bray PF. Genetics of arterial prothrombotic risk states. Exp Biol Med 2001;226:409\u2013419.","journal-title":"Exp Biol Med"},{"key":"2912_CR16","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1002\/sim.1375","volume":"22","author":"D Burr","year":"2003","unstructured":"Burr D, Doss H, Glen EC, Goldschmidt-Clrmont PJ. A meta-analysis of studies on the association of the platelet PIA polymorphism of glycoprotein IIIa and risk of coronary heart disease. Statist Med 2003;22:1741\u20131760.","journal-title":"Statist Med"},{"key":"2912_CR17","doi-asserted-by":"crossref","first-page":"2573","DOI":"10.1161\/01.ATV.19.10.2573","volume":"19","author":"J Mikkelsson","year":"1999","unstructured":"Mikkelsson J, Perola M, Laippala P, et al. Glycoprotein IIIa Pl(A) Polymorphism associates with progression of coronary artery disease and with myocardial infarction in an autopsy series of middle-aged men who died suddenly. Arterioscler Thromb Vasc Biol 1999;19:2573\u20132578.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2912_CR18","unstructured":"Mammen EF, Comp PC, Gosselin R, et al. PFA-100TM system: A new method for assessment of platelet dysfunction."},{"key":"2912_CR19","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/j.1365-3148.1995.tb00227.x","volume":"3","author":"S Kekom\u00e4ki","year":"1995","unstructured":"Kekom\u00e4ki S, Partanen J, Kekom\u00e4ki R. Platelet alloantigens HPA-1, -2,-3, -5 and -6b in Finns. Transfus Med 1995;3:193\u2013198.","journal-title":"Transfus Med"},{"key":"2912_CR20","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1055\/s-0037-1615618","volume":"85","author":"SJ Marciniak","year":"2001","unstructured":"Marciniak SJ, Jordan RE, Mascelli MA. Effect of Ca2+ chelation on the platelet inhibitory ability of the GPIIb\/IIIa antagonists abciximab, eptifibatide and tirofiban. Thromb Haemost 2001;85:539\u2013543.","journal-title":"Thromb Haemost"},{"key":"2912_CR21","doi-asserted-by":"crossref","first-page":"7795","DOI":"10.1074\/jbc.275.11.7795","volume":"276","author":"W Puzon-McLaughlin","year":"2000","unstructured":"Puzon-McLaughlin W, Kamata T, Takada Y. Multiple discontinuous ligand-mimetic antibody binding sites define a ligand binding pocket in integrin \u03b1IIb\u03b23. J Biol Chem 2000;276:7795\u20137802.","journal-title":"J Biol Chem"},{"key":"2912_CR22","first-page":"117","volume":"9","author":"EF Plow","year":"1989","unstructured":"Plow EF, Ginsberg MH. Cellular adhesion: GPIIb-IIIa as a prototypic adhesion receptor. Progress in Hemostasis and Thrombosis 1989;9:117\u2013156","journal-title":"Progress in Hemostasis and Thrombosis"},{"key":"2912_CR23","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1023\/A:1012991303381","volume":"12","author":"DJ Kereiakes","year":"2001","unstructured":"Kereiakes DJ, Lorenz T, Young JJ, et al. Differential effects of citrate versus PPACK anticoagulation on measured platelet inhibition by abciximab, eptifibatide and tirofiban. J Thrombosis Thrombolysis 2001;12:123\u2013127.","journal-title":"J Thrombosis Thrombolysis"},{"key":"2912_CR24","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1161\/01.CIR.99.17.2231","volume":"99","author":"M Quinn","year":"1999","unstructured":"Quinn M, Deering A, Stewart M, Cox D, Foley B, Fitzgerald D. Quantifying GPIIb\/IIIa receptor binding using 2 monoclonal antibodies. Discriminating abciximab and small molecular weight antagonists. Circulation 1999;99:2231\u20132238.","journal-title":"Circulation"},{"key":"2912_CR25","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1055\/s-0037-1614176","volume":"84","author":"LK Jennings","year":"2000","unstructured":"Jennings LK, Haga JH, Slack SM. Differential expression of a ligand induced binding site (LIBS) by GPIIb-IIIa ligand recognition peptides and parenteral antagonists. Thromb Haemost 2000;84:1095\u20131102.","journal-title":"Thromb Haemost"},{"key":"2912_CR26","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1161\/01.CIR.96.5.1488","volume":"96","author":"DR Phillips","year":"1997","unstructured":"Phillips DR, Teng W, Arfsten A, et al. Effect of Ca sup 2+ on GP IIb-IIIa interactions with integrilin: Enhanced GP IIb-IIIa binding and inhibition of platelet aggregation by reductions in the concentration of ionized calcium in plasma anticoagulated with citrate. Circulation 1997;96:1488\u20131494.","journal-title":"Circulation"},{"key":"2912_CR27","doi-asserted-by":"crossref","first-page":"13102","DOI":"10.1016\/S0021-9258(18)51601-X","volume":"264","author":"B Steiner","year":"1989","unstructured":"Steiner B, Cousot D, Trzeciak A, Gillessen D, Hadvary P. Ca2+-dependent binding of a synthetic arg-gly-asp (RGD) peptide to a single site on the purified platelet glycoprotein IIb-IIIa complex. J Biol Chem 1989;264:13102\u201313108.","journal-title":"J Biol Chem"},{"key":"2912_CR28","doi-asserted-by":"crossref","first-page":"3256","DOI":"10.1182\/blood.V98.12.3256","volume":"98","author":"FF O\u2019Connor","year":"2001","unstructured":"O\u2019Connor FF, Shields DS, Fitzgerald A, Cannon CP, Braunwald E, Fitzgerald DJ. Genetic variation in glycoprotein IIb\/IIIa (GPIIb\/IIIa) as a determinant of the responses to an oral GPIIb\/IIIa antagonist in patients with unstable coronary syndromes. Blood 2001;98:3256\u20133260.","journal-title":"Blood"},{"key":"2912_CR29","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1161\/01.CIR.101.9.1013","volume":"101","author":"AD Michelson","year":"2000","unstructured":"Michelson AD, Furman MI, Goldschmidt-Clermont P, et al. Platelet GP IIIa P1A polymorphisms display different sensitivities to agonists. Circulation 2000;101:1013\u20131018.","journal-title":"Circulation"},{"key":"2912_CR30","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1067\/mhj.2002.119763","volume":"143","author":"G\u00d6 Wheeler","year":"2002","unstructured":"Wheeler G\u00d6, Braden GA, Bray PF, Marciniak SJ, Marcelli MA, Sane DC. Reduced inhibition by abciximab in platelets with the PIA2 polymorphism. Am Heart J 2002;143:76\u201382.","journal-title":"Am Heart J"},{"key":"2912_CR31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0014-2999(02)02391-9","volume":"454","author":"M Rozalski","year":"2002","unstructured":"Rozalski M, Watala C. Antagonists of platelet fibrinogen receptor are less effective in carriers of PI(A2) polymorphism of beta(3) integrin. Eur J Pharmacol 2002;454:1\u20138.","journal-title":"Eur J Pharmacol"},{"key":"2912_CR32","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1097\/00008571-200210000-00011","volume":"12","author":"A-A Weber","year":"2002","unstructured":"Weber A-A, Jacobs C, Meila D, et al. No evidence for the influence of the human platelet antigen 1 polymorphism on the antiplatelet effects of glycoprotein IIb\/IIIa inhibitors. Pharmacogenetics 2002;12:581\u2013583.","journal-title":"Pharmacogenetics"},{"key":"2912_CR33","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1177\/153537020122600504","volume":"226","author":"MS Williams","year":"2001","unstructured":"Williams MS, Bray PF. Genetics of arterial prothrombotic risk states. Exp Biol Med 2001;226:409\u2013419.","journal-title":"Exp Biol Med"},{"key":"2912_CR34","doi-asserted-by":"crossref","first-page":"25235","DOI":"10.1016\/S0021-9258(18)47235-3","volume":"269","author":"JC Loftus","year":"1994","unstructured":"Loftus JC, Smith JW, Ginsberg MH. Integrin-mediated cell adhesion: The extracellular face. J Biol Chem 1994;269:25235\u201325238.","journal-title":"J Biol Chem"}],"container-title":["Journal of Thrombosis and Thrombolysis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-005-2912-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11239-005-2912-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-005-2912-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,16]],"date-time":"2021-07-16T21:27:52Z","timestamp":1626470872000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11239-005-2912-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,8]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,8]]}},"alternative-id":["2912"],"URL":"https:\/\/doi.org\/10.1007\/s11239-005-2912-2","relation":{},"ISSN":["0929-5305","1573-742X"],"issn-type":[{"value":"0929-5305","type":"print"},{"value":"1573-742X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,8]]}}}